Bone Biologics Corporation (BBLG)
USD 0.86
(1.91%)
USD 0.86
(1.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 479.57 Thousand USD | 110.91% |
| 2022 | - USD | -299.18% |
| 2021 | - USD | -33.51% |
| 2020 | -825.01 Thousand USD | 66.29% |
| 2019 | -2.44 Million USD | -2.72% |
| 2018 | -2.79 Million USD | 9.29% |
| 2017 | -2.62 Million USD | 85.28% |
| 2016 | -20.41 Million USD | -48.84% |
| 2015 | -11.99 Million USD | -297.08% |
| 2014 | -3.01 Million USD | -637.62% |
| 2013 | - USD | -146592.06% |
| 2012 | -5231.00 USD | 90.7% |
| 2011 | -4520.00 USD | 0.0% |
| 2010 | -3000.00 USD | 0.0% |
| 2009 | -3000.00 USD | 77.52% |
| 2008 | -13.34 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -903.54 Thousand USD | 0.0% |
| 2024 Q2 | -809.66 Thousand USD | 0.0% |
| 2023 Q1 | -2.58 Million USD | -389.8% |
| 2023 Q4 | -769.78 Thousand USD | 63.01% |
| 2023 Q3 | -2.08 Million USD | 51.72% |
| 2023 FY | - USD | -114.43% |
| 2023 Q2 | -4.31 Million USD | -66.76% |
| 2022 Q4 | 891.86 Thousand USD | 173.15% |
| 2022 Q2 | -469.3 Thousand USD | 28.51% |
| 2022 Q1 | -656.42 Thousand USD | -306.75% |
| 2022 FY | - USD | -299.18% |
| 2022 Q3 | -1.21 Million USD | -159.81% |
| 2021 Q2 | -231.88 Thousand USD | -28.16% |
| 2021 Q3 | -229.78 Thousand USD | 0.9% |
| 2021 Q4 | -161.38 Thousand USD | 29.77% |
| 2021 FY | - USD | -33.51% |
| 2021 Q1 | -180.92 Thousand USD | 12.36% |
| 2020 Q2 | -132.7 Thousand USD | 60.97% |
| 2020 Q4 | -206.43 Thousand USD | -41.56% |
| 2020 FY | - USD | 66.29% |
| 2020 Q1 | -340.05 Thousand USD | -22.48% |
| 2020 Q3 | -145.82 Thousand USD | -9.88% |
| 2019 Q3 | -301.31 Thousand USD | 55.64% |
| 2019 Q2 | -679.23 Thousand USD | 42.88% |
| 2019 Q1 | -1.18 Million USD | 4.0% |
| 2019 FY | - USD | -2.72% |
| 2019 Q4 | -277.62 Thousand USD | 7.86% |
| 2018 Q3 | 813.1 Thousand USD | 194.53% |
| 2018 FY | - USD | 9.29% |
| 2018 Q4 | -1.23 Million USD | -252.35% |
| 2018 Q2 | -860.12 Thousand USD | 21.57% |
| 2018 Q1 | -1.09 Million USD | 16.32% |
| 2017 Q1 | -2.16 Million USD | 31.27% |
| 2017 FY | - USD | 85.28% |
| 2017 Q4 | -1.31 Million USD | -15.9% |
| 2017 Q3 | -1.13 Million USD | -157.25% |
| 2017 Q2 | 1.97 Million USD | 191.43% |
| 2016 Q2 | -4.28 Million USD | 34.62% |
| 2016 FY | - USD | -48.84% |
| 2016 Q4 | -3.14 Million USD | 18.52% |
| 2016 Q1 | -6.55 Million USD | 13.59% |
| 2016 Q3 | -3.85 Million USD | 10.05% |
| 2015 Q4 | -7.59 Million USD | -155.77% |
| 2015 Q3 | -2.96 Million USD | -481.93% |
| 2015 Q2 | -510 Thousand USD | 44.74% |
| 2015 Q1 | -922.84 Thousand USD | -17.43% |
| 2015 FY | - USD | -297.08% |
| 2014 Q4 | -785.89 Thousand USD | 55.23% |
| 2014 FY | - USD | -637.62% |
| 2014 Q3 | -1.75 Million USD | -1480.45% |
| 2014 Q2 | -111.07 Thousand USD | 25.49% |
| 2014 Q1 | -149.08 Thousand USD | -26.49% |
| 2013 FY | - USD | -146592.06% |
| 2013 Q3 | -119.03 Thousand USD | -26.26% |
| 2013 Q2 | -94.27 Thousand USD | -9.29% |
| 2013 Q4 | -117.86 Thousand USD | 0.99% |
| 2013 Q1 | -86.26 Thousand USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 90.7% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 77.52% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 100.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | -3000.00 USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 103.556% |
| Cerus Corporation | -26.53 Million USD | 101.807% |
| OrthoPediatrics Corp. | -8.38 Million USD | 105.722% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 104.57% |
| Talis Biomedical Corporation | -66.04 Million USD | 100.726% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 102.876% |
| Inogen, Inc. | -45.67 Million USD | 101.05% |
| Spectral AI, Inc. | -12.26 Million USD | 103.911% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 101.006% |
| CVRx, Inc. | -38.73 Million USD | 101.238% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 113.593% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 103.961% |
| Orthofix Medical Inc. | -86.98 Million USD | 100.551% |
| Venus Concept Inc. | -26.11 Million USD | 101.837% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 100.964% |
| Bioventus Inc. | -23.07 Million USD | 102.079% |
| BrainsWay Ltd. | -2.31 Million USD | 120.752% |
| Envoy Medical, Inc. | -18.23 Million USD | 102.63% |
| electroCore, Inc. | -17.76 Million USD | 102.7% |
| IceCure Medical Ltd | -15.25 Million USD | 103.144% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 100.964% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 102.845% |
| MaxCyte, Inc. | -44.12 Million USD | 101.087% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 104.079% |
| Nexalin Technology, Inc. | -5.69 Million USD | 108.425% |
| PAVmed Inc | -75.74 Million USD | 100.633% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 100.892% |
| RxSight, Inc. | -41.03 Million USD | 101.169% |
| Sight Sciences, Inc. | -49.41 Million USD | 100.97% |
| SI-BONE, Inc. | -34.44 Million USD | 101.392% |
| TELA Bio, Inc. | -40.63 Million USD | 101.18% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 100.823% |
| Treace Medical Concepts, Inc. | -39 Million USD | 101.229% |
| LivaNova PLC | 39.01 Million USD | 98.771% |
| 908 Devices Inc. | -34.02 Million USD | 101.409% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 100.434% |
| Nemaura Medical Inc. | -7.28 Million USD | 106.581% |
| NeuroPace, Inc. | -22.83 Million USD | 102.1% |
| LENSAR, Inc. | -8.71 Million USD | 105.503% |
| Apyx Medical Corporation | -18.11 Million USD | 102.648% |
| Cutera, Inc. | -136.56 Million USD | 100.351% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 114.189% |
| BioSig Technologies, Inc. | -28.15 Million USD | 101.704% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 80.939% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 102.285% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 99.875% |
| Axonics, Inc. | 7.77 Million USD | 93.832% |
| Outset Medical, Inc. | -153.78 Million USD | 100.312% |
| IRIDEX Corporation | -7.44 Million USD | 106.439% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 100.489% |
| IRadimed Corporation | 20.8 Million USD | 97.694% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 105.949% |
| INVO Bioscience, Inc. | -6.88 Million USD | 106.97% |
| Telesis Bio, Inc. | -40.49 Million USD | 101.184% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 98.692% |
| Varex Imaging Corporation | 67.2 Million USD | 99.286% |
| Quipt Home Medical Corp. | 44.07 Million USD | 98.912% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 104.412% |
| Pulmonx Corporation | -55.09 Million USD | 100.87% |
| Dynatronics Corporation | -976 Thousand USD | 149.136% |
| Modular Medical, Inc. | -17.1 Million USD | 102.804% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 103.311% |
| Semler Scientific, Inc. | 23.58 Million USD | 97.967% |
| InMode Ltd. | 196.28 Million USD | 99.756% |
| Bruker Corporation | 599 Million USD | 99.92% |
| Cytosorbents Corporation | -28.81 Million USD | 101.665% |
| DexCom, Inc. | 916.7 Million USD | 99.948% |
| Align Technology, Inc. | 799.03 Million USD | 99.94% |
| Viveve Medical, Inc. | -20.61 Million USD | 102.326% |
| ZimVie Inc. | 91.07 Million USD | 99.473% |
| Movano Inc. | -29.12 Million USD | 101.647% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 110.88% |
| Nexalin Technology, Inc. | -5.69 Million USD | 108.425% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 113.593% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 100.246% |
| Profound Medical Corp. | -27.12 Million USD | 101.768% |
| Insulet Corporation | 323.6 Million USD | 99.852% |
| enVVeno Medical Corporation | -25.01 Million USD | 101.917% |
| Surmodics, Inc. | 1.18 Million USD | 59.632% |
| iCAD, Inc. | -6.56 Million USD | 107.305% |
| Nuwellis, Inc. | -16.35 Million USD | 102.932% |
| Biotricity, Inc. | -8.82 Million USD | 105.432% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 100.495% |
| Aethlon Medical, Inc. | -11.84 Million USD | 104.047% |
| InspireMD, Inc. | -20.91 Million USD | 102.293% |
| PAVmed Inc. | -75.74 Million USD | 100.633% |
| BIOLASE, Inc. | -15.13 Million USD | 103.168% |
| Beyond Air, Inc. | -59.03 Million USD | 100.812% |
| FONAR Corporation | 28.25 Million USD | 98.302% |
| AxoGen, Inc. | -13.32 Million USD | 103.598% |
| Vivani Medical, Inc. | -26.6 Million USD | 101.802% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 98.046% |
| Inari Medical, Inc. | 7.11 Million USD | 93.258% |
| UFP Technologies, Inc. | 72.74 Million USD | 99.341% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 114.164% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 107.79% |
| Tenon Medical, Inc. | -15.52 Million USD | 103.088% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 103.141% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 101.156% |
| AdaptHealth Corp. | -171.09 Million USD | 100.28% |
| Sintx Technologies, Inc. | -6.6 Million USD | 107.266% |
| NanoVibronix, Inc. | -3.43 Million USD | 113.961% |
| Quanterix Corporation | -38.08 Million USD | 101.259% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 104.412% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -1498.573% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 100.173% |
| TransMedics Group, Inc. | -7.6 Million USD | 106.308% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 102.203% |
| NeuroMetrix, Inc. | -7.09 Million USD | 106.759% |
| Hyperfine, Inc. | -47.06 Million USD | 101.019% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 100.822% |
| Biomerica, Inc. | -5.99 Million USD | 108.002% |
| AVITA Medical, Inc. | -39.56 Million USD | 101.212% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 105.228% |
| Silk Road Medical, Inc | -45.08 Million USD | 101.064% |